Gómez Rodríguez N, Ibáñez Ruán J, González Pérez M, et al. Primary hypertrophic osteoarthropathy (pachydermoperiostosis): report of two familial cases and literature review[J]. Reumatol Clin, 2009, 5(6): 259⁃263. DOI: 10.1016/j.reuma.2009.01.007.
[2]
Uppal S, Diggle CP, Carr IM, et al. Mutations in 15⁃hydroxypro⁃staglandin dehydrogenase cause primary hypertrophic osteoarthro⁃pathy[J]. Nat Genet, 2008, 40(6): 789⁃793. DOI: 10.1038/ng.153.
[3]
Martínez⁃Ferrer A, Peris P, Alós L, et al. Prostaglandin E2 and bone turnover markers in the evaluation of primary hypertrophic osteoarthropathy (pachydermoperiostosis): a case report[J]. Clin Rheumatol, 2009, 28(10): 1229⁃1233. DOI: 10.1007/s10067⁃009⁃1197⁃9.
[4]
Zhang Z, He JW, Fu WZ, et al. Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization[J]. J Clin Endocrinol Metab, 2013, 98(5): E923⁃E933. DOI: 10.1210/jc.2012⁃3568.
[5]
Ghosn S, Uthman I, Dahdah M, et al. Treatment of pachydermo⁃periostosis pachydermia with botulinum toxin type A[J]. J Am Acad Dermatol, 2010, 63(6): 1036⁃1041. DOI: 10.1016/j.jaad.2009.08.067.
[6]
Tariq M, Azeem Z, Ali G. Mutation in the HPGD gene encoding NAD+ dependent 15⁃hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC)[J]. J Med Genet, 2009, 46(1): 14⁃20. DOI: 10.1136/jmg.2008.061234.
[7]
Kanai N, Lu R, Satriano JA et al. Identification and characterization of a prostaglandin transporter[J]. Science, 1995, 268(5212): 866⁃869. DOI: 10.1126/science.7754369.
[8]
Busch J, Frank V, Bachmann N, et al. Mutations in the prostag⁃landin transporter SLCO2A1 cause primary hypertrophic osteoarthropathy with digital clubbing[J]. J Invest Dermatol, 2012, 132(10): 2473⁃2476. DOI: 10.1038/jid.2012.146.